FI861923A0 - Kompositioner, vilka anvaends vid framstaellning av mikropartiklar som skall extruderas och vilka aostadkommer ett foerlaengt frigivande av ett biologiskt aktivt medel, och de saolunda erhaollna mikropartiklarna. - Google Patents

Kompositioner, vilka anvaends vid framstaellning av mikropartiklar som skall extruderas och vilka aostadkommer ett foerlaengt frigivande av ett biologiskt aktivt medel, och de saolunda erhaollna mikropartiklarna.

Info

Publication number
FI861923A0
FI861923A0 FI861923A FI861923A FI861923A0 FI 861923 A0 FI861923 A0 FI 861923A0 FI 861923 A FI861923 A FI 861923A FI 861923 A FI861923 A FI 861923A FI 861923 A0 FI861923 A0 FI 861923A0
Authority
FI
Finland
Prior art keywords
ett
vilka
och
composition
saolunda
Prior art date
Application number
FI861923A
Other languages
English (en)
Other versions
FI861923A (fi
Inventor
Jehan-Yves Drouin
Michel Veillard
Original Assignee
Rhone Poulenc Sante
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Sante filed Critical Rhone Poulenc Sante
Publication of FI861923A0 publication Critical patent/FI861923A0/fi
Publication of FI861923A publication Critical patent/FI861923A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
FI861923A 1985-05-09 1986-05-08 Kompositioner, vilka anvaends vid framstaellning av mikropartiklar som skall extruderas och vilka aostadkommer ett foerlaengt frigivande av ett biologiskt aktivt medel, och de saolunda erhaollna mikropartiklarna. FI861923A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8507013A FR2581541B1 (fr) 1985-05-09 1985-05-09 Nouvelles compositions pharmaceutiques permettant la liberation prolongee d'un principe actif et leur procede de preparation

Publications (2)

Publication Number Publication Date
FI861923A0 true FI861923A0 (fi) 1986-05-08
FI861923A FI861923A (fi) 1986-11-10

Family

ID=9319093

Family Applications (1)

Application Number Title Priority Date Filing Date
FI861923A FI861923A (fi) 1985-05-09 1986-05-08 Kompositioner, vilka anvaends vid framstaellning av mikropartiklar som skall extruderas och vilka aostadkommer ett foerlaengt frigivande av ett biologiskt aktivt medel, och de saolunda erhaollna mikropartiklarna.

Country Status (14)

Country Link
EP (1) EP0204596B1 (fi)
JP (1) JPS61260029A (fi)
KR (1) KR860008774A (fi)
AT (1) ATE45283T1 (fi)
AU (1) AU579012B2 (fi)
CA (1) CA1266841A (fi)
DE (1) DE3664867D1 (fi)
DK (1) DK217286A (fi)
ES (1) ES8802206A1 (fi)
FI (1) FI861923A (fi)
FR (1) FR2581541B1 (fi)
MA (1) MA20670A1 (fi)
NZ (1) NZ216082A (fi)
ZA (1) ZA863431B (fi)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5198226A (en) * 1986-01-30 1993-03-30 Syntex (U.S.A.) Inc. Long acting nicardipine hydrochloride formulation
US4940556A (en) * 1986-01-30 1990-07-10 Syntex (U.S.A.) Inc. Method of preparing long acting formulation
IL81419A0 (en) * 1986-01-30 1987-08-31 Syntex Inc Long acting sustained release pharmaceutical compositions containing dihydropyridines and their preparation
SE457326B (sv) * 1986-02-14 1988-12-19 Lejus Medical Ab Foerfarande foer framstaellning av en snabbt soenderfallande kaerna innehaallande bl a mikrokristallin cellulosa
DE3612212A1 (de) * 1986-04-11 1987-10-15 Basf Ag Verfahren zur herstellung von festen pharmazeutischen formen
NL8701335A (nl) * 1986-06-21 1988-01-18 Sandoz Ag Orale farmaceutische preparaten.
FR2634376B1 (fr) 1988-07-21 1992-04-17 Farmalyoc Nouvelle forme unitaire, solide et poreuse comprenant des microparticules et/ou des nanoparticules, ainsi que sa preparation
FR2663818B1 (fr) * 1990-06-29 1993-07-09 Rhone Poulenc Nutrition Animale Procede de preparation de granules de principes actifs par extrusion.
DE4021678C2 (de) * 1990-07-07 1994-07-07 Merz & Co Gmbh & Co Verfahren zur Herstellung klein dimensionierter Formkörper mit hohem Etofibrat-Gehalt und kontrollierter Wirkstoff-Freisetzung, deren Verwendung und daraus bestehende oral verabreichbare Applikationsformen
DE4031881C2 (de) * 1990-10-08 1994-02-24 Sanol Arznei Schwarz Gmbh Lösungsmittelfreie, oral zu verabreichende pharmazeutische Zubereitung mit verzögerter Wirkstoffreisetzung und Verfahren zu deren Herstellung
WO1993007859A1 (en) * 1991-10-23 1993-04-29 Warner-Lambert Company Novel pharmaceutical pellets and process for their production
EP0641195B1 (de) * 1992-05-22 1996-04-10 Gödecke Aktiengesellschaft Verfahren zur herstellung retardierter arzneimittelzubereitungen
US5700410A (en) * 1992-10-16 1997-12-23 Nippon Shinyaku Co., Ltd. Method of manufacturing wax matrices
ES2061394B1 (es) * 1993-02-05 1995-06-16 Robert S A Lab Procedimiento de fabricacion de un granulado de citrato potasico con cesion retardada.
US5843347A (en) * 1993-03-23 1998-12-01 Laboratoire L. Lafon Extrusion and freeze-drying method for preparing particles containing an active ingredient
FR2702968B1 (fr) * 1993-03-23 1995-06-23 Lafon Labor Procédé de préparation de particules renfermant un ingrédient actif par extrusion et lyophilisation .
BE1006990A5 (nl) * 1993-04-22 1995-02-07 Univ Gent Werkwijze en samenstelling om een aktief bestanddeel in een vaste toedieningsvorm te brengen.
FR2710500B1 (fr) * 1993-09-27 1995-12-01 Virbac Laboratoires Composition et système à administration orale pour animaux, leur procédé de préparation et leurs applications.
DE4422881A1 (de) * 1993-10-25 1995-04-27 Bayer Ag Kolloidal dispergierbare Wirkstoff-Formulierungen
DK0744941T3 (da) * 1994-02-16 2003-09-29 Abbott Lab Fremgangsmåde til fremstilling af findelte farmaceutiske formuleringer
DE4413350A1 (de) * 1994-04-18 1995-10-19 Basf Ag Retard-Matrixpellets und Verfahren zu ihrer Herstellung
GB9422154D0 (en) 1994-11-03 1994-12-21 Euro Celtique Sa Pharmaceutical compositions and method of producing the same
US5965161A (en) * 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
DE29502547U1 (de) * 1995-02-16 1995-03-30 Roehm Gmbh Thermoplastisches Überzugs- und Bindemittel für Arzneiformen
DE19531277A1 (de) * 1995-08-25 1997-02-27 Basf Ag Verwendung von Lipiden als Hilfsmittel bei der Herstellung von festen Arzneiformen nach dem Schmelzextrusionsverfahren
DE19539363A1 (de) * 1995-10-23 1997-04-24 Basf Ag Verfahren zur Herstellung von festen Arzneiformen
GB2344520A (en) * 1998-12-08 2000-06-14 Phares Pharm Res Nv Pharmaceutical carriers comprising lipids and polymers
DE10029201A1 (de) 2000-06-19 2001-12-20 Basf Ag Verfahren zur Herstellung fester oraler Darreichungsformen mit retardierender Wirkstoffreisetzung
CN1446119A (zh) 2000-08-03 2003-10-01 宝洁公司 生产颗粒组分的方法和设备
WO2018140941A1 (en) * 2017-01-30 2018-08-02 Case Western Reserve University Polymer constructs for controlled release of guest agents

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3146167A (en) * 1961-10-05 1964-08-25 Smith Kline French Lab Method of preparing sustained release pellets and products thereof
US3247065A (en) * 1963-10-14 1966-04-19 Hoffmann La Roche Free-flowing coated ascorbic acid
US3965256A (en) * 1972-05-16 1976-06-22 Synergistics Slow release pharmaceutical compositions
DE3024416C2 (de) * 1980-06-28 1982-04-15 Gödecke AG, 1000 Berlin Verfahren zur Herstellung von Arzneimitteln mit retardierter Wirkstoff-Freisetzung
FR2515035A1 (fr) * 1981-10-26 1983-04-29 Rhone Poulenc Sante Nouvelle forme galenique solide pour administration par voie orale et son procede de fabrication
IT1200217B (it) * 1986-09-30 1989-01-05 Valducci Roberto Membrana per uso farmaceutico ed industriale

Also Published As

Publication number Publication date
ATE45283T1 (de) 1989-08-15
EP0204596A1 (fr) 1986-12-10
FI861923A (fi) 1986-11-10
DE3664867D1 (en) 1989-09-14
FR2581541A1 (fr) 1986-11-14
ES554821A0 (es) 1988-04-16
AU5722486A (en) 1986-11-13
KR860008774A (ko) 1986-12-18
JPS61260029A (ja) 1986-11-18
DK217286D0 (da) 1986-05-09
NZ216082A (en) 1989-01-06
ZA863431B (en) 1986-12-30
DK217286A (da) 1986-11-10
MA20670A1 (fr) 1986-12-31
ES8802206A1 (es) 1988-04-16
EP0204596B1 (fr) 1989-08-09
FR2581541B1 (fr) 1988-05-20
AU579012B2 (en) 1988-11-10
CA1266841A (fr) 1990-03-20

Similar Documents

Publication Publication Date Title
FI861923A0 (fi) Kompositioner, vilka anvaends vid framstaellning av mikropartiklar som skall extruderas och vilka aostadkommer ett foerlaengt frigivande av ett biologiskt aktivt medel, och de saolunda erhaollna mikropartiklarna.
FI884604A0 (fi) Implanterbar, biologiskt nedbrytbart aktivmedels frigivningssystem.
DK0544144T3 (da) Fast farmaceutisk retardform
FI92014C (fi) Kiinteä, hallitusti vapauttava lääkeaineen kantoaineena käytettävä matriisi
ATE222500T1 (de) Enythropoietin enthaltendes arzneimittelabgabesystem
FR2545354B1 (fr) Composition pharmaceutique pour l'administration parenterale a base de nimodipin et procede pour sa preparation
FI870616A (fi) Valon vaikutuksesta hajoavina ja lämpöstabiloituina kalvoina käytettäviä polymeerikoostumuksia
ATE13545T1 (de) Stabilisatorzusammensetzungen, halogenhaltige polymerzusammensetzungen, welche diese enthalten, und geformte gegenstaende, welche die polymerzusammensetzungen enthalten.
KR860000864A (ko) 디히드로피리딘을 함유하는 고상 약제 및 그 제조방법
ES2039377T3 (es) Un supositorio.
IT1224405B (it) Composti attivi sul sistema cardiovascolare
DE69207301D1 (de) Substituierte 3-Piperazinylalkyl 2,3-Dihydro-4H-1,3-Benzoxazin-4-One, deren Herstellung und Verwendung in Heilkunde
ES2054268T3 (es) Aditivos polimericos.
ATE135696T1 (de) Diamino-s-triazinonderivate und diese enthaltende selbstlöschende polymere zusammensetzungen
FI912269A (fi) 3'-deamino - 4'deoxi - 4'-amino- 8 -fluorantracykliner och framstaellningsfoerfaranden foer dessa.
ES2121070T3 (es) 3,9-bis(dialquilamino)-2,4,8,10-tetraoxa-3,9-difosfaespiro(5,5)-undecanos y composiciones estabilizadas.
DE69403110T2 (de) Zyklische Angiopeptin Derivate, deren Herstellung und pharmazeutische Zusammensetzungen
MC2102A1 (fr) Application de micelles mixtes
ES2062072T3 (es) Clorofibras con un caracter antiseptico permanente y procedimiento para obtenerlas.
KR920006354A (ko) 피라졸로퀴놀린 유도체
IT1274024B (it) Derivati polimerici del benzopiran-2-one ad attivita' immunotropa, loro uso e composizioni farmaceutiche che li contengono
TH3543A (th) อนุพันธ์ใหม่ของเบนซิมิดาโซล
ES2125970T3 (es) Composiciones que inhiben la transferencia de colorante que comprenden agentes dispersantes polimeros.

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: RHONE-POULENC SANTE